SWP
UTHR icon

Strategic Wealth Partners’s United Therapeutics UTHR Stock Holding History

Strategic Wealth Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38K Hold
64
– – ﹤0.01% 563
2025
Q4 		$31.2K Hold
64
– – ﹤0.01% 609
2025
Q3 		$26.8K Hold
64
– – ﹤0.01% 670
2025
Q2 		$18.4K Buy
+64
New +$19.1K ﹤0.01% 666

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Strategic Wealth Partners's UTHR Position: Q1 2026 in Review

Strategic Wealth Partners held its United Therapeutics (UTHR) position steady in Q1 2026 at 64 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #563.

Strategic Wealth Partners first reported a position in UTHR in Q2 2025 and has held it in 4 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Strategic Wealth Partners held 64 shares of United Therapeutics worth $38K as of Q1 2026.
  • Strategic Wealth Partners left its United Therapeutics share count unchanged in Q1 2026.
  • United Therapeutics made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q1 2026, its #563 holding.
  • Strategic Wealth Partners first reported a position in United Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.